DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc.with Losses to Contact the Firm
Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer [Yahoo! Finance]
Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Akero Therapeutics, Inc. (AKRO)
AKERO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Akero Therapeutics, Inc. and Encourages Investors to Contact the Firm